Stabilization of GTSE1 by cyclin D1–CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis
eLife · 2025
DOI: 10.7554/elife.101075 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Nelson García-Vázquez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, Cyclin D1, Cell Proliferation, Cyclin-Dependent Kinase 6. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
In healthy cells, cyclin D1 is expressed during the G1 phase of the cell cycle, where it activates CDK4 and CDK6. Its dysregulation is a well-established oncogenic driver in numerous human cancers. The cancer-related function of cyclin D1 has been primarily studied by focusing on the phosphorylation of the retinoblastoma (RB) gene product. Here, using an integrative approach combining bioinformatic analyses and biochemical experiments, we show that GTSE1 (G-Two and S phases expressed protein 1), a protein positively regulating cell cycle progression, is a previously unrecognized substrate of cyclin D1–CDK4/6 in tumor cells overexpressing cyclin D1 during G1 and subsequent phases. The phosphorylation of GTSE1 mediated by cyclin D1–CDK4/6 inhibits GTSE1 degradation, leading to high levels of GTSE1 across all cell cycle phases. Functionally, the phosphorylation of GTSE1 promotes cellular proliferation and is associated with poor prognosis within a pan-cancer cohort. Our findings provide insights into cyclin D1’s role in cell cycle control and oncogenesis beyond RB phosphorylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.
- Department of Medicine, New York University Grossman School of Medicine, New York, United States.
- Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, United States.
- Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
ORCID-Profile: Tania J González-Robles, Daniele Simoneschi, Kelly V Ruggles, Sharon Kaisari, Michele Pagano
Förderung
- NIH HHS
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- National Institutes of Health
- Life Sciences Research Foundation
- European Molecular Biology Organization
Zitieren
APA
García-Vázquez, N., González-Robles, T. J., Lane, E., Spasskaya, D., Zhang, Q., Kerzhnerman, M. A., Jeong, Y., Collu, M., Simoneschi, D., Ruggles, K. V., Róna, G., Kaisari, S., & Pagano, M. (2025). Stabilization of GTSE1 by cyclin D1–CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis. eLife. https://doi.org/10.7554/elife.101075
Vancouver
García-Vázquez N, González-Robles TJ, Lane E, Spasskaya D, Zhang Q, Kerzhnerman MA, et al. Stabilization of GTSE1 by cyclin D1–CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis. eLife. 2025. doi:10.7554/elife.101075
BibTeX
@article{GarcaVzquez2025,
author = {García-Vázquez, Nelson and González-Robles, Tania J and Lane, Ethan and Spasskaya, Daria and Zhang, Qingyue and Kerzhnerman, Marc A and Jeong, YeonTae and Collu, Marta and Simoneschi, Daniele and Ruggles, Kelly V and Róna, Gergely and Kaisari, Sharon and Pagano, Michele},
title = {Stabilization of GTSE1 by cyclin D1–CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.101075}
}
EUVIMED